Medistim ASA (MD1) Stock Statistics & Valuation Metrics

Medistim ASA has a market cap or net worth of €416.60M. The enterprise value is €3.75B.

Medistim ASA has 18,337,336 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medistim ASA’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 21.26%.

The current PE Ratio of Medistim ASA is 34.6. Medistim ASA’s PEG ratio is ―.

In the last 12 months, Medistim ASA had revenue of 562.60M and earned 103.83M in profits. Earnings per share was 5.67.

In the last 12 months, operating cash flow was 150.65M and capital expenditures 0.00, giving a free cash flow of 150.65M billion.

Medistim ASA pays an annual dividend of ―, resulting in a dividend yield of ―

Medistim ASA upcoming earnings date is Mar 4, 2026, TBA (Confirmed).

Medistim ASA as a current ratio of 4.00, with Debt / Equity ratio of 5.74%

In the past 12 months, Medistim ASA has paid 30.41M in taxes.

Medistim ASA EV to EBITDA ratio is 16.67, with an EV/FCF ratio of 18.92.

Medistim ASA has €96.35M in cash and marketable securities with €26.17M in debt, giving a net cash position of €74.32M billion.

Gross margin is 72.80%, with operating margin of 23.30%, and net profit margin of 18.46%.

The average price target for Medistim ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―